The Current State and Future of CRISPR-Cas9 gRNA Design Tools

Recent years have seen the development of computational tools to assist researchers in performing CRISPR-Cas9 experiment optimally. More specifically, these tools aim to maximize on-target activity (guide efficiency) while also minimizing potential off-target effects (guide specificity) by analyzing...

Full description

Bibliographic Details
Main Authors: Laurence O. W. Wilson, Aidan R. O’Brien, Denis C. Bauer
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00749/full
id doaj-154b9d1123a648c1b842dbf5c7df7561
record_format Article
spelling doaj-154b9d1123a648c1b842dbf5c7df75612020-11-24T20:48:24ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-07-01910.3389/fphar.2018.00749353115The Current State and Future of CRISPR-Cas9 gRNA Design ToolsLaurence O. W. Wilson0Aidan R. O’Brien1Aidan R. O’Brien2Denis C. Bauer3Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, AustraliaCommonwealth Scientific and Industrial Research Organisation, Sydney, NSW, AustraliaDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, ACT, AustraliaCommonwealth Scientific and Industrial Research Organisation, Sydney, NSW, AustraliaRecent years have seen the development of computational tools to assist researchers in performing CRISPR-Cas9 experiment optimally. More specifically, these tools aim to maximize on-target activity (guide efficiency) while also minimizing potential off-target effects (guide specificity) by analyzing the features of the target site. Nonetheless, currently available tools cannot robustly predict experimental success as prediction accuracy depends on the approximations of the underlying model and how closely the experimental setup matches the data the model was trained on. Here, we present an overview of the available computational tools, their current limitations and future considerations. We discuss new trends around personalized health by taking genomic variants into account when predicting target sites as well as discussing other governing factors that can improve prediction accuracy.https://www.frontiersin.org/article/10.3389/fphar.2018.00749/fullCRISPR-Cas9bioinformaticsoff-target finderactivity predictionchromatinmachine learning
collection DOAJ
language English
format Article
sources DOAJ
author Laurence O. W. Wilson
Aidan R. O’Brien
Aidan R. O’Brien
Denis C. Bauer
spellingShingle Laurence O. W. Wilson
Aidan R. O’Brien
Aidan R. O’Brien
Denis C. Bauer
The Current State and Future of CRISPR-Cas9 gRNA Design Tools
Frontiers in Pharmacology
CRISPR-Cas9
bioinformatics
off-target finder
activity prediction
chromatin
machine learning
author_facet Laurence O. W. Wilson
Aidan R. O’Brien
Aidan R. O’Brien
Denis C. Bauer
author_sort Laurence O. W. Wilson
title The Current State and Future of CRISPR-Cas9 gRNA Design Tools
title_short The Current State and Future of CRISPR-Cas9 gRNA Design Tools
title_full The Current State and Future of CRISPR-Cas9 gRNA Design Tools
title_fullStr The Current State and Future of CRISPR-Cas9 gRNA Design Tools
title_full_unstemmed The Current State and Future of CRISPR-Cas9 gRNA Design Tools
title_sort current state and future of crispr-cas9 grna design tools
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-07-01
description Recent years have seen the development of computational tools to assist researchers in performing CRISPR-Cas9 experiment optimally. More specifically, these tools aim to maximize on-target activity (guide efficiency) while also minimizing potential off-target effects (guide specificity) by analyzing the features of the target site. Nonetheless, currently available tools cannot robustly predict experimental success as prediction accuracy depends on the approximations of the underlying model and how closely the experimental setup matches the data the model was trained on. Here, we present an overview of the available computational tools, their current limitations and future considerations. We discuss new trends around personalized health by taking genomic variants into account when predicting target sites as well as discussing other governing factors that can improve prediction accuracy.
topic CRISPR-Cas9
bioinformatics
off-target finder
activity prediction
chromatin
machine learning
url https://www.frontiersin.org/article/10.3389/fphar.2018.00749/full
work_keys_str_mv AT laurenceowwilson thecurrentstateandfutureofcrisprcas9grnadesigntools
AT aidanrobrien thecurrentstateandfutureofcrisprcas9grnadesigntools
AT aidanrobrien thecurrentstateandfutureofcrisprcas9grnadesigntools
AT deniscbauer thecurrentstateandfutureofcrisprcas9grnadesigntools
AT laurenceowwilson currentstateandfutureofcrisprcas9grnadesigntools
AT aidanrobrien currentstateandfutureofcrisprcas9grnadesigntools
AT aidanrobrien currentstateandfutureofcrisprcas9grnadesigntools
AT deniscbauer currentstateandfutureofcrisprcas9grnadesigntools
_version_ 1716807842462171136